BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 43 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $19,000 | -100.0% | 18,000 | -100.0% | 0.00% | -100.0% |
| Q2 2018 | $43,996,000 | -27.5% | 41,234,000 | -30.2% | 0.93% | -22.3% |
| Q1 2018 | $60,714,000 | -12.3% | 59,076,000 | -7.6% | 1.19% | -10.2% |
| Q4 2017 | $69,268,000 | -13.4% | 63,930,000 | -10.7% | 1.33% | -12.4% |
| Q3 2017 | $79,987,000 | +4.8% | 71,592,000 | +4.4% | 1.52% | +3.8% |
| Q2 2017 | $76,305,000 | +3.6% | 68,589,000 | +5.9% | 1.46% | +6.0% |
| Q1 2017 | $73,667,000 | +16.5% | 64,770,000 | +15.5% | 1.38% | +18.4% |
| Q4 2016 | $63,226,000 | +24.7% | 56,067,000 | +32.7% | 1.16% | +58.8% |
| Q3 2016 | $50,719,000 | +12.5% | 42,248,000 | +4.3% | 0.73% | +5.0% |
| Q2 2016 | $45,097,000 | -16.3% | 40,514,000 | -13.0% | 0.70% | -15.2% |
| Q1 2016 | $53,895,000 | -19.3% | 46,556,000 | -9.4% | 0.82% | -19.9% |
| Q4 2015 | $66,747,000 | -0.1% | 51,401,000 | +0.7% | 1.03% | +0.6% |
| Q3 2015 | $66,798,000 | +9.0% | 51,055,000 | +29.5% | 1.02% | +15.9% |
| Q2 2015 | $61,272,000 | +1.5% | 39,435,000 | -3.7% | 0.88% | +1.0% |
| Q1 2015 | $60,367,000 | -14.2% | 40,940,000 | -31.4% | 0.87% | -15.7% |
| Q4 2014 | $70,392,000 | +5.6% | 59,647,000 | -4.9% | 1.03% | +0.7% |
| Q3 2014 | $66,638,000 | -2.1% | 62,750,000 | -2.6% | 1.03% | +1.1% |
| Q2 2014 | $68,092,000 | +67.2% | 64,416,000 | +73.4% | 1.02% | +59.7% |
| Q1 2014 | $40,718,000 | -3.7% | 37,155,000 | -6.4% | 0.64% | +19.5% |
| Q4 2013 | $42,286,000 | – | 39,691,000 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|